Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001553878-15-000001
Filing Date
2015-01-05
Accepted
2015-01-05 17:10:03
Documents
1
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7904
  Complete submission text file 0001553878-15-000001.txt   9283
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address
Reid Laurence (Reporting) CIK: 0001492749 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 15506168